$2.94
Today
as of Aug 5, 16:47 ET
Last 30 days
Recent Press Releases & News
Are Medical Stocks Lagging Perspective Therapeutics, Inc. (CATX) This Year?
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
Perspective Therapeutics (CATX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Overview
52-week range
$1.96
$6.16
23% of range
Avg surprise (last 3)
+8.2%
Avg reaction (last 2)
+5.0%
100% positive
Latest IV / EM
335%
EM ±56.0% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-0.25 | $-0.29 | +13.8% | 0.0% | +3.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.35 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.30 | $-0.30 | 0.0% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.25 | $-0.28 | +10.7% | — | +6.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.21 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.18 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.25 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.37 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.40 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.27 | -$0.30 | +10.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-28M | — | $-28M | $-24M | $-22M | — | $-19M | $-14M |
| Net income | $-26M | — | $-26M | $-21M | $-18M | — | $-15M | $-12M |
| EPS (diluted) | $-0.25 | — | $-0.35 | $-0.29 | $-0.25 | — | $-0.21 | $-0.18 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $54M | $31M | $27M | $29M | $44M | $62M | $226M | $252M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $275M | $148M | $178M | $196M | $216M | $231M | $270M | $294M |
| Total assets | $411M | $267M | $295M | $311M | $329M | $341M | $391M | $386M |
| Long-term debt | $2M | — | $2M | $2M | $2M | — | $2M | $2M |
| Total liabilities | $63M | $60M | $53M | $45M | $45M | $50M | $63M | $45M |
| Total equity | $347M | $207M | $242M | $266M | $285M | $291M | $328M | $341M |